The Tissue Microarray Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Tissue Microarray Market:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
In accordance with The Business Research Company’s comprehensive analysis detailed in the Tissue Microarray Global Market Report 2024, the landscape of the tissue microarray market has undergone a notable surge in recent times. This ascendancy is projected to persist, propelling the market from $11.17 billion in 2024 to an anticipated $12.36 billion by the same year, manifesting a compelling compound annual growth rate (CAGR) of 10.7%. This robust growth during the historical period is intricately linked to the ascendance of precision medicine, the strides made in drug discovery and development, the imperative need for efficient analysis, the escalating prevalence of chronic diseases, and the catalytic role played by biobanking initiatives.
Forecasts for the tissue microarray market size further accentuate its trajectory toward substantial expansion, with a projected valuation of $18.68 billion by 2028, coupled with a commendable CAGR of 10.9%. This anticipated growth in the forecast period is underpinned by transformative factors such as the advent of digital pathology, the broadening spectrum of applications, the burgeoning biopharmaceutical industry, reinforced regulatory support and standards, and the pivotal integration of artificial intelligence (AI) and machine learning (ML). Noteworthy trends that are poised to shape the market landscape in this phase encompass breakthroughs in imaging technologies, the development of 3D tissue microarrays, the ascendancy of high-content screening, the impetus behind standardization initiatives, and the seamless integration of single-cell analysis.
The growing number of cancer cases is expected to propel the growth of the tissue microarray market going forward. Cancer is a category of illnesses that can develop in any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Tissue arrays are used in oncology to examine the expression of cancer-related biomarkers in various tumor samples. For instance, in January 2024, according to the American Cancer Society Inc., a US-based non-profit organization, it is anticipated that there will be 609,820 cancer deaths and 1,958,310 new cancer cases in the US during 2022. Therefore, the growing number of cancer cases is driving the growth of the tissue microarray market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp
The tissue microarray market covered in this report is segmented –
1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting
3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals
A discernible trend gaining prominence within the tissue microarray domain is the strategic partnerships forged among major industry players. Eminent companies are increasingly engaging in collaborative efforts to foster innovative synergies in the realm of tissue microarray technologies. A compelling illustration of this trend unfolded in November 2022 when The Cureline Group, a US-based translational and precision medicine Contract Research Organization (CRO), specializing in Human Biological Specimen (HBS) biobanking and laboratory services, joined forces with Cellecta Inc., a prominent US-based provider of RNAi and CRISPR screening products and services. This strategic alliance, known as Tissue 2 Target Services, brings together the distinctive competencies of the two entities in molecular analysis of cells and tissues, coupled with human biospecimen management. The collaboration aims to deliver pre-clinical and translational research facilities specializing in gene target and biomarker discovery services, thereby streamlining workflows.
Similarly, in September 2022, Ultivue Inc., a US-based biotechnology firm renowned for developing reagent-based solutions optimizing biological information extraction from cells and tissue samples, initiated a groundbreaking partnership with ngTMA, a Switzerland-based Translational Research Unit (TRU) platform affiliated with the University of Bern. This collaboration, geared towards advancing multiplexed immunofluorescence (mIF) assays and leveraging novel TMA technologies, seeks to unlock spatial analysis in scientific research. Moreover, it aspires to elevate the caliber of Tissue Microarrays (TMAs) utilized in clinical and translational research, marking a noteworthy stride towards enhanced precision and efficacy in these critical domains.
The tissue microarray market report table of contents includes:
1. Executive Summary
2. Tissue Microarray Market Characteristics
3. Tissue Microarray Market Trends And Strategies
4. Tissue Microarray Market - Macro Economic Scenario
5. Global Tissue Microarray Market Size and Growth
.....
32. Global Tissue Microarray Market Competitive Benchmarking
33. Global Tissue Microarray Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Tissue Microarray Market
35. Tissue Microarray Market Future Outlook and Potential Analysis
36. Appendix
Related Reports:
https://topprnews.com/critical-illness-insurance-market-share/
https://topprnews.com/specialty-fats-and-oils-market-share/
https://topprnews.com/sugar-toppings-market-analysis/
https://goodprnews.com/critical-illness-insurance-market-share/
https://goodprnews.com/specialty-fats-and-oils-market-size/
https://goodprnews.com/sugar-toppings-market-analysis/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
It is a practical and effective tool for high-throughput molecular analysis of tissues that is helping to identify new diagnostic and prognostic markers and targets in human cancers, and has a range of potential applications in basic research, prognostic oncology and drug discovery.
The growing need of targeted treatments for various chronic diseases like cancer, genetic diseases, among others has boosted the growth of the market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/1213According to a recent study report published by the Market Research Future analysts, the global tissue microarray market is growing at a double digit growth rate; mainly due to the increasing application of tissue microarray in drug discovery and oncology, automated analysis of results and influence of technology are some of the major factors that fosters the growth of global tissue microarray market.
Moreover, wide application of tissue microarray in pathology is another factor which is impelling the growth of tissue microarray market.On the other hand tissue microarray may not be fruitful for heterogeneous cancers and the sample may not represent the entire tumour which may hamper the market growth.
Global Tissue Microarray Market - Competitive AnalysisAbcam plc (U.K), Externautics (Italy), Asterand Bioscience (U.S), Auria Biopankki (Finland), US Biomax Inc. (U.S), Protein Biotechnologies Inc. (U.S), OriGene Technologies Inc (U.S), Novus Biologicals, LLC (U.S) and OriGene Technologies Inc.(U.S) are some of the prominent players at the forefront of competition in the global tissue microarray market and are profiled in MRFR Analysis.
The American market for tissue microarray holds the largest share and it comprises of two regions namely North America and South America.
According Centers for Disease Control and Prevention, each year more than 1.5 million cases of cancer are diagnosed, including about 15,000 cases among children younger than 20 years, and more than 590,000 deaths from cancer.
